Trump’s Most Favored Nation Drug Pricing is Back
In a press conference, President Donald J. Trump announced that he would sign an executive order that ties drug pricing to prices in other developed countries. He also vowed to cut out the “middlemen” to bring the new prices to American citizens.
In a press conference this morning, President Donald J. Trump announced that he will be signing an executive order to lower drug prices. He first mentioned his intention in a post on Truth Social on Mother’s Day, saying implementing a policy that ties prices here in the United States to those in other developed countries would “reduce drug prices by 30% to 80%.”
During the press conference, he said the Most Favored Nation rule will lower prices immediately, and he would use “the power of the federal government to ensure that we are paying the same prices as other countries.”
To do this, Trump said he will cut out “the middlemen” and facilitate the direct sale of drugs at the Most Favored Nation price directly to the American citizen.
He also indicated that “he will open up America's market to safe and legal imports of affordable drugs from other countries, putting dramatic downward pressure on prices,” and implement tariffs on countries that don’t make an effort to provide equal pricing.
This is a developing story.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Women PCPs Have Equal or Better Medicare Patient Outcomes Than Men PCPs in Value-Based Care Model
June 24th 2025Women primary care providers (PCPs) treating Medicare patients in a value-based care model achieved better patient outcomes and earned more per patient than male counterparts, despite receiving equal patient satisfaction ratings, highlighting a potential for value-based payment to help close the gender pay gap.
Read More
A Progress Report on Chronic GVHD. The Grades Are Not So Great
June 24th 2025There has been no or some progress in most areas since a National Institute of Health consensus development project in 2020, according to a group of experts. But exception is important: Prevention of moderate or severe chronic graft-vs.-host disease.
Read More
